Clinical Trial Update: Extracorporeal CO2 Removal in COPD Exacerbation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating extracorporeal CO2 removal in COPD exacerbation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: University of Turin, Italy | Conditions: COPD Exacerbation | Phase 2 | Status: COMPLETED